Key statistics
As of last trade, Ginkgo Bioworks Holdings Inc (DNA:NYQ) traded at 9.82, 96.40% above the 52 week low of 5.00 set on Apr 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 9.98 |
|---|---|
| High | 10.02 |
| Low | 9.43 |
| Bid | 9.79 |
| Offer | 9.82 |
| Previous close | 10.10 |
| Average volume | 1.58m |
|---|---|
| Shares outstanding | 57.59m |
| Free float | 43.84m |
| P/E (TTM) | -- |
| Market cap | 581.66m USD |
| EPS (TTM) | -6.22 USD |
Data delayed at least 15 minutes, as of Feb 09 2026 18:25 GMT.
More ▼
Press releases
- Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark
- Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
- Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
- Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment
- Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety
- Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC
- STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy
- Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health
More ▼
